Treatment strategy for insomnia disorder: Japanese expert consensus
PurposeThere is a lack of evidence regarding answers for clinical questions about treating insomnia disorder. This study aimed to answer the following clinical questions: (1) how to use each hypnotic and non-pharmacological treatment differently depending on clinical situations and (2) how to reduce...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1168100/full |
_version_ | 1797830929763270656 |
---|---|
author | Yoshikazu Takaesu Yoshikazu Takaesu Hitoshi Sakurai Yumi Aoki Yumi Aoki Masahiro Takeshima Kenya Ie Kenya Ie Kentaro Matsui Kentaro Matsui Tomohiro Utsumi Tomohiro Utsumi Akiyoshi Shimura Isa Okajima Nozomu Kotorii Nozomu Kotorii Hidehisa Yamashita Masahiro Suzuki Kenichi Kuriyama Kenichi Kuriyama Eiji Shimizu Eiji Shimizu Kazuo Mishima Koichiro Watanabe Ken Inada |
author_facet | Yoshikazu Takaesu Yoshikazu Takaesu Hitoshi Sakurai Yumi Aoki Yumi Aoki Masahiro Takeshima Kenya Ie Kenya Ie Kentaro Matsui Kentaro Matsui Tomohiro Utsumi Tomohiro Utsumi Akiyoshi Shimura Isa Okajima Nozomu Kotorii Nozomu Kotorii Hidehisa Yamashita Masahiro Suzuki Kenichi Kuriyama Kenichi Kuriyama Eiji Shimizu Eiji Shimizu Kazuo Mishima Koichiro Watanabe Ken Inada |
author_sort | Yoshikazu Takaesu |
collection | DOAJ |
description | PurposeThere is a lack of evidence regarding answers for clinical questions about treating insomnia disorder. This study aimed to answer the following clinical questions: (1) how to use each hypnotic and non-pharmacological treatment differently depending on clinical situations and (2) how to reduce or stop benzodiazepine hypnotics using alternative pharmacological and non-pharmacological treatments.MethodsExperts were asked to evaluate treatment choices based on 10 clinical questions about insomnia disorder using a nine-point Likert scale (1 = “disagree” to 9 = “agree”). The responses of 196 experts were collected, and the answers were categorized into first-, second-, and third-line recommendations.ResultsThe primary pharmacological treatment, lemborexant (7.3 ± 2.0), was categorized as a first-line recommendation for sleep initiation insomnia, and lemborexant (7.3 ± 1.8) and suvorexant (6.8 ± 1.8) were categorized as the first-line recommendations for sleep maintenance insomnia. Regarding non-pharmacological treatments for primary treatment, sleep hygiene education was categorized as the first-line recommendation for both sleep initiation (8.4 ± 1.1) and maintenance insomnia (8.1 ± 1.5), while multicomponent cognitive behavioral therapy for insomnia was categorized as the second-line treatment for both sleep initiation (5.6 ± 2.3) and maintenance insomnia (5.7 ± 2.4). When reducing or discontinuing benzodiazepine hypnotics by switching to other medications, lemborexant (7.5 ± 1.8) and suvorexant (6.9 ± 1.9) were categorized as first-line recommendations.ConclusionExpert consensus indicates that orexin receptor antagonists and sleep hygiene education are recommended as first-line treatments in most clinical situations to treat insomnia disorder. |
first_indexed | 2024-04-09T13:44:52Z |
format | Article |
id | doaj.art-a070f998a10d4db58129b7afca76789f |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-04-09T13:44:52Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-a070f998a10d4db58129b7afca76789f2023-05-09T05:38:26ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-05-011410.3389/fpsyt.2023.11681001168100Treatment strategy for insomnia disorder: Japanese expert consensusYoshikazu Takaesu0Yoshikazu Takaesu1Hitoshi Sakurai2Yumi Aoki3Yumi Aoki4Masahiro Takeshima5Kenya Ie6Kenya Ie7Kentaro Matsui8Kentaro Matsui9Tomohiro Utsumi10Tomohiro Utsumi11Akiyoshi Shimura12Isa Okajima13Nozomu Kotorii14Nozomu Kotorii15Hidehisa Yamashita16Masahiro Suzuki17Kenichi Kuriyama18Kenichi Kuriyama19Eiji Shimizu20Eiji Shimizu21Kazuo Mishima22Koichiro Watanabe23Ken Inada24Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, JapanDepartment of Neuropsychiatry, Faculty of Medicine, Kyorin University, Tokyo, JapanDepartment of Neuropsychiatry, Faculty of Medicine, Kyorin University, Tokyo, JapanDepartment of Neuropsychiatry, Faculty of Medicine, Kyorin University, Tokyo, JapanPsychiatric and Mental Health Nursing, St. Luke’s International University, Tokyo, JapanDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, JapanDivision of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JapanDivision of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki, JapanDepartment of Clinical Laboratory, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, JapanDepartment of Sleep-Wake Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, JapanDepartment of Sleep-Wake Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, JapanDepartment of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan0Department of Psychiatry, Tokyo Medical University, Tokyo, Japan1Department of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan2Kotorii Isahaya Hospital, Nagasaki, Japan3Department of Psychiatry, School of Medicine, Kurume University, Fukuoka, Japan4Minna No Sleep and Stress Care Clinic, Hiroshima, Japan5Department of Psychiatry, Nihon University School of Medicine, Tokyo, JapanDepartment of Sleep-Wake Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan6Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan7Research Center for Child Mental Development, Chiba University, Chiba, Japan8Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, JapanDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, JapanDepartment of Neuropsychiatry, Faculty of Medicine, Kyorin University, Tokyo, Japan9Department of Psychiatry, School of Medicine, Kitasato University, Tokyo, JapanPurposeThere is a lack of evidence regarding answers for clinical questions about treating insomnia disorder. This study aimed to answer the following clinical questions: (1) how to use each hypnotic and non-pharmacological treatment differently depending on clinical situations and (2) how to reduce or stop benzodiazepine hypnotics using alternative pharmacological and non-pharmacological treatments.MethodsExperts were asked to evaluate treatment choices based on 10 clinical questions about insomnia disorder using a nine-point Likert scale (1 = “disagree” to 9 = “agree”). The responses of 196 experts were collected, and the answers were categorized into first-, second-, and third-line recommendations.ResultsThe primary pharmacological treatment, lemborexant (7.3 ± 2.0), was categorized as a first-line recommendation for sleep initiation insomnia, and lemborexant (7.3 ± 1.8) and suvorexant (6.8 ± 1.8) were categorized as the first-line recommendations for sleep maintenance insomnia. Regarding non-pharmacological treatments for primary treatment, sleep hygiene education was categorized as the first-line recommendation for both sleep initiation (8.4 ± 1.1) and maintenance insomnia (8.1 ± 1.5), while multicomponent cognitive behavioral therapy for insomnia was categorized as the second-line treatment for both sleep initiation (5.6 ± 2.3) and maintenance insomnia (5.7 ± 2.4). When reducing or discontinuing benzodiazepine hypnotics by switching to other medications, lemborexant (7.5 ± 1.8) and suvorexant (6.9 ± 1.9) were categorized as first-line recommendations.ConclusionExpert consensus indicates that orexin receptor antagonists and sleep hygiene education are recommended as first-line treatments in most clinical situations to treat insomnia disorder.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1168100/fullinsomniahypnoticscognitive behavioral therapysleep hygiene education (SHE)orexin receptor antagonistsbenzodiazepine |
spellingShingle | Yoshikazu Takaesu Yoshikazu Takaesu Hitoshi Sakurai Yumi Aoki Yumi Aoki Masahiro Takeshima Kenya Ie Kenya Ie Kentaro Matsui Kentaro Matsui Tomohiro Utsumi Tomohiro Utsumi Akiyoshi Shimura Isa Okajima Nozomu Kotorii Nozomu Kotorii Hidehisa Yamashita Masahiro Suzuki Kenichi Kuriyama Kenichi Kuriyama Eiji Shimizu Eiji Shimizu Kazuo Mishima Koichiro Watanabe Ken Inada Treatment strategy for insomnia disorder: Japanese expert consensus Frontiers in Psychiatry insomnia hypnotics cognitive behavioral therapy sleep hygiene education (SHE) orexin receptor antagonists benzodiazepine |
title | Treatment strategy for insomnia disorder: Japanese expert consensus |
title_full | Treatment strategy for insomnia disorder: Japanese expert consensus |
title_fullStr | Treatment strategy for insomnia disorder: Japanese expert consensus |
title_full_unstemmed | Treatment strategy for insomnia disorder: Japanese expert consensus |
title_short | Treatment strategy for insomnia disorder: Japanese expert consensus |
title_sort | treatment strategy for insomnia disorder japanese expert consensus |
topic | insomnia hypnotics cognitive behavioral therapy sleep hygiene education (SHE) orexin receptor antagonists benzodiazepine |
url | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1168100/full |
work_keys_str_mv | AT yoshikazutakaesu treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT yoshikazutakaesu treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT hitoshisakurai treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT yumiaoki treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT yumiaoki treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT masahirotakeshima treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kenyaie treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kenyaie treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kentaromatsui treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kentaromatsui treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT tomohiroutsumi treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT tomohiroutsumi treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT akiyoshishimura treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT isaokajima treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT nozomukotorii treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT nozomukotorii treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT hidehisayamashita treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT masahirosuzuki treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kenichikuriyama treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kenichikuriyama treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT eijishimizu treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT eijishimizu treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT kazuomishima treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT koichirowatanabe treatmentstrategyforinsomniadisorderjapaneseexpertconsensus AT keninada treatmentstrategyforinsomniadisorderjapaneseexpertconsensus |